Search Results for: Victoria Gray

Weekly reads: big CRISPR mtg, Mesoblast good news, Neuralink spiked

March 11, 2023 / By / 1 Comment
Victoria Gray, CRISPR meeting

Where do things stand with potential applications of CRISPR and other gene editing technologies in patients? Overall, things are looking very positive. CRISPR human trials This week the third big international human genome editing meeting took place in London. The summit addressed numerous potential clinical applications. It was good to see the agenda included quite …

Weekly reads: big CRISPR mtg, Mesoblast good news, Neuralink spiked Read More »

Weekly reads: stem cell good news, bad news on sickle cell, MS, IPSCs

January 7, 2023 / By / 1 Comment
victoria gray family crispr sickle cell b

Let’s start with some stem cell good news on evolving approaches to treat sickle cell disease involving stem cells. Then on another related front things were more concerning. Stem cell good news on sickle cell disease, a complication Sickle Cell Disease News reports Adding Briquilimab Boosts Success of Sickle Cell Stem Cell Transplant. This is a …

Weekly reads: stem cell good news, bad news on sickle cell, MS, IPSCs Read More »

Weekly science reads: senescence, alt CRISPR, sickle cell update

January 9, 2022 / By / 1 Comment
victoria gray family crispr sickle cell b

Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic? It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end …

Weekly science reads: senescence, alt CRISPR, sickle cell update Read More »

Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more

February 1, 2021 / By / Leave a Comment
victoria gray family crispr sickle cell b

I’m playing catch-up on some reading given how busy I’ve been and this includes a groundbreaking NEJM pub on CRISPR for Sickle Cell and Thalassemia. CRISPR for Sickle Cell From December, here’s the key paper in the NEJM: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. There’s a lot to like about this clinical …

Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more Read More »